Dr. Robert Doebele of the University of Colorado Cancer Center spoke to ALK and ROS1 patients about how and why their cancers become resistant to treatment and what options are available.
Logo
You are here
Mechanisms of ALK Resistance & Implications for Treatment
Related Content
Article
From the Grace Archives | Originally Published April 22, 20
